SIMRIT KAHLON: Open Payments
NPI 1013466341 · LANCASTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$345 in 15 payments from 8 companies in 2025. Trend: 2023 $227 · 2024 $458 · 2025 $345
Food & beverage: $345
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $97 |
| Lundbeck LLC | 2 | $61 |
| Janssen Pharmaceuticals, Inc | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $32 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
| Tris Pharma Inc | 1 | $24 |
| Corium, LLC | 2 | $19 |
Products named: VRAYLAR, REXULTI, INVEGA SUSTENNA, CAPLYTA, INGREZZA, Dyanavel XR, Azstarys, SPRAVATO.
Industry payments across PA — which companies pay providers there.
